Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1c89ce4d9ac03f9acd8ddede1162f94d http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2b65ef0c364f36a81a3412180600cfd7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_12de03b2643ae95b55c484a22e433f26 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-08 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47 |
filingDate |
2006-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6458528152759d7faf3d0e59cd72927b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3871e648436a5b366e147acafef771e |
publicationDate |
2006-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2006106358-A2 |
titleOfInvention |
Use of nk-3 receptor antagonists for the treatment of nausea and vomiting |
abstract |
This invention relates to the treatment or prevention of nausea and/or vomiting by the administration of a NK-3 receptor antagonist. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9545426-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10085970-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2016216578-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8642631-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9889118-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10525033-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9084765-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9119836-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2014202535-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2796171-A1 |
priorityDate |
2005-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |